Small TUK, Participants AT. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet. 1998;352:1649–55.

Article  Google Scholar 

Isselbacher EM. Thoracic and abdominal aortic aneurysms. Circulation. 2005;111:816–28.

Article  PubMed  Google Scholar 

Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet. 2005;365:1577–89.

Article  CAS  PubMed  Google Scholar 

Elefteriades JA, Farkas EA. Thoracic aortic aneurysm clinically pertinent controversies and uncertainties. J Am Coll Cardiol. 2010;55:841–57.

Article  CAS  PubMed  Google Scholar 

Liu B, Granville DJ, Golledge J, Kassiri Z. Pathogenic mechanisms and the potential of drug therapies for aortic aneurysm. Am J Physiol Heart Circ Physiol. 2020;318:H652–70.

Article  PubMed  PubMed Central  Google Scholar 

Aggarwal S, Qamar A, Sharma V, Sharma A. Abdominal aortic aneurysm: a comprehensive review. Exp Clin Cardiol. 2011;16:11–5.

PubMed  PubMed Central  Google Scholar 

Dake MD, Miller DC, Semba CP, Mitchell RS, Walker PJ, Liddell RP. Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med. 1994;331:1729–34.

Article  CAS  PubMed  Google Scholar 

Johansson G, Markstrom U, Swedenborg J. Ruptured thoracic aortic aneurysms: a study of incidence and mortality rates. J Vasc Surg. 1995;21:985–8.

Article  CAS  PubMed  Google Scholar 

Mitchell RS, Dake MD, Sembra CP, Fogarty TJ, Zarins CK, Liddel RP, Miller DC. Endovascular stent-graft repair of thoracic aortic aneurysms. J Thorac Cardiovasc Surg. 1996;111:1054–62.

Article  CAS  PubMed  Google Scholar 

Shrestha M, Kaufeld T, Beckmann E, Fleissner F, Umminger J, Abd Alhadi F, Boethig D, Krueger H, Haverich A, Martens A. Total aortic arch replacement with a novel 4-branched frozen elephant trunk prosthesis: Single-center results of the first 100 patients. J Thorac Cardiovasc Surg. 2016;152(148–159): e141.

Google Scholar 

Vainas T, Lubbers T, Stassen FR, Herngreen SB, van Dieijen-Visser MP, Bruggeman CA, Kitslaar PJ, Schurink GW. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation. 2003;107:1103–5.

Article  PubMed  Google Scholar 

Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects. Blood. 2009;113:2878–87.

Article  CAS  PubMed  Google Scholar 

Acosta-Martin AE, Panchaud A, Chwastyniak M, Dupont A, Juthier F, Gautier C, Jude B, Amouyel P, Goodlett DR, Pinet F. Quantitative mass spectrometry analysis using PAcIFIC for the identification of plasma diagnostic biomarkers for abdominal aortic aneurysm. PLoS ONE. 2011;6:e28698.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gamberi T, Puglia M, Guidi F, Magherini F, Bini L, Marzocchini R, Modesti A, Modesti PA. A proteomic approach to identify plasma proteins in patients with abdominal aortic aneurysm. Mol Biosyst. 2011;7:2855–62.

Article  CAS  PubMed  Google Scholar 

Yagi H, Nishigori M, Murakami Y, Osaki T, Muto S, Iba Y, Minatoya K, Ikeda Y, Ishibashi-Ueda H, Morisaki T, et al. Discovery of novel biomarkers for atherosclerotic aortic aneurysm through proteomics-based assessment of disease progression. Sci Rep. 2020;10:6429. (Publisher Correction: Sci Rep 2020, 10:10474).

Nordon IM, Brar R, Hinchliffe RJ, Cockerill G, Thompson MM. Proteomics and pitfalls in the search for potential biomarkers of abdominal aortic aneurysms. Vascular. 2010;18:264–8.

Article  PubMed  Google Scholar 

Finoulst I, Pinkse M, Van Dongen W, Verhaert P. Sample preparation techniques for the untargeted LC-MS-based discovery of peptides in complex biological matrices. J Biomed Biotechnol. 2011;2011:245291.

Article  PubMed  PubMed Central  Google Scholar 

Cao Z, Tang HY, Wang H, Liu Q, Speicher DW. Systematic comparison of fractionation methods for in-depth analysis of plasma proteomes. J Proteome Res. 2012;11:3090–100.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nishigori M, Yagi H, Mochiduki A, Minamino N. Multiomics approach to identify novel biomarkers for dilated cardiomyopathy: proteome and transcriptome analyses of 4C30 dilated cardiomyopathy mouse model. Biopolymers. 2016;106:491–502.

Article  CAS  PubMed  Google Scholar 

Masuda T, Tomita M, Ishihama Y. Phase transfer surfactant-aided trypsin digestion for membrane proteome analysis. J Proteome Res. 2008;7:731–40.

Article  CAS  PubMed  Google Scholar 

Rappsilber J, Ishihama Y, Mann M. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal Chem. 2003;75:663–70.

Article  CAS  PubMed  Google Scholar 

Yuasa Y, Osaki T, Makino H, Iwamoto N, Kishimoto I, Usami M, Minamino N, Harada-Shiba M. Proteomic analysis of proteins eliminated by low-density lipoprotein apheresis. Ther Apher Dial. 2014;18:93–102.

Article  CAS  PubMed  Google Scholar 

Burillo E, Jorge I, Martinez-Lopez D, Camafeita E, Blanco-Colio LM, Trevisan-Herraz M, Ezkurdia I, Egido J, Michel JB, Meilhac O, et al. Quantitative HDL proteomics identifies peroxiredoxin-6 as a biomarker of human abdominal aortic aneurysm. Sci Rep. 2016;6:38477.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carlsson L, Nystrom LE, Sundkvist I, Markey F, Lindberg U. Actin polymerizability is influenced by profilin, a low molecular weight protein in non-muscle cells. J Mol Biol. 1977;115:465–83.

Article  CAS  PubMed  Google Scholar 

Alkam D, Feldman EZ, Singh A, Kiaei M. Profilin1 biology and its mutation, actin(g) in disease. Cell Mol Life Sci. 2017;74:967–81.

Article  CAS  PubMed  Google Scholar 

Caglayan E, Romeo GR, Kappert K, Odenthal M, Sudkamp M, Body SC, Shernan SK, Hackbusch D, Vantler M, Kazlauskas A, Rosenkranz S. Profilin-1 is expressed in human atherosclerotic plaques and induces atherogenic effects on vascular smooth muscle cells. PLoS ONE. 2010;5:e13608.

Article  PubMed  PubMed Central  Google Scholar 

Wang Y, Zhang J, Gao H, Zhao S, Ji X, Liu X, You B, Li X, Qiu J. Profilin-1 promotes the development of hypertension-induced artery remodeling. J Histochem Cytochem. 2014;62:298–310.

Article  PubMed  PubMed Central  Google Scholar 

Matsumoto K, Maniwa T, Tanaka T, Satoh K, Okunishi H, Oda T. Proteomic analysis of calcified abdominal and thoracic aortic aneurysms. Int J Mol Med. 2012;30:417–29.

Article  CAS  PubMed  Google Scholar 

Moustafa-Bayoumi M, Alhaj MA, El-Sayed O, Wisel S, Chotani MA, Abouelnaga ZA, Hassona MD, Rigatto K, Morris M, Nuovo G, et al. Vascular hypertrophy and hypertension caused by transgenic overexpression of profilin 1. J Biol Chem. 2007;282:37632–9.

Article  CAS  PubMed  Google Scholar 

Volanakis JE, Narayana SV. Complement factor D, a novel serine protease. Protein Sci. 1996;5:553–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

White RT, Damm D, Hancock N, Rosen BS, Lowell BB, Usher P, Flier JS, Spiegelman BM. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem. 1992;267:9210–3.

Article  CAS  PubMed  Google Scholar 

Vasilenko MA, Kirienkova EV, Skuratovskaia DA, Zatolokin PA, Mironyuk NI, Litvinova LS. The role of production of adipsin and leptin in the development of insulin resistance in patients with abdominal obesity. Dokl Biochem Biophys. 2017;475:271–6.

Article  CAS  PubMed  Google Scholar 

Prentice RL, Zhao S, Johnson M, Aragaki A, Hsia J, Jackson RD, Rossouw JE, Manson JE, Hanash SM. Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases. Genome Med. 2013;5:112.

Article  PubMed  PubMed Central  Google Scholar 

Ohtsuki T, Satoh K, Shimizu T, Ikeda S, Kikuchi N, Satoh T, Kurosawa R, Nogi M, Sunamura S, Yaoita N, et al. Identification of Adipsin as a Novel Prognostic Biomarker in Patients With Coronary Artery Disease. J Am Heart Assoc. 2019;8:e013716.

Article  PubMed  PubMed Central  Google Scholar 

Shahini N, Michelsen AE, Nilsson PH, Ekholt K, Gullestad L, Broch K, Dahl CP, Aukrust P, Ueland T, Mollnes TE, et al. The alternative complement pathway is dysregulated in patients with chronic heart failure. Sci Rep. 2017;7:42532.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hertle E, Arts IC, van der Kallen CJ, Feskens EJ, Schalkwijk CG, Stehouwer CD, van Greevenbroek MM. The alternative complement pathway is longitudinally associated with adverse cardiovascular outcomes. The CODAM study Thromb Haemost. 2016;115:446–57.